Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

1.56
-0.2400-13.33%
Post-market: 1.600.0382+2.45%17:27 EST
Volume:1.47M
Turnover:2.42M
Market Cap:111.09M
PE:-3.09
High:1.79
Open:1.78
Low:1.56
Close:1.80
52wk High:2.01
52wk Low:0.2425
Shares:71.21M
Float Shares:59.52M
Volume Ratio:0.51
T/O Rate:2.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5047
EPS(LYR):-0.3663
ROE:-60.06%
ROA:-29.33%
PB:2.49
PE(LYR):-4.26

Loading ...

Ovid Therapeutics Names Dr. Petra Kaufmann as Chief Medical Officer

Reuters
·
Yesterday

Ovid Therapeutics Appoints DR. Petra Kaufmann as Chief Medical Officer

THOMSON REUTERS
·
Yesterday

Ovid Therapeutics Showcases Neurotherapeutics Pipeline Targeting Drug-Resistant Seizures and Neural Hyperexcitability

Reuters
·
Nov 14

BTIG Keeps Their Buy Rating on Ovid Therapeutics (OVID)

TIPRANKS
·
Nov 14

Ovid Therapeutics Q3 revenue slightly beats expectations

Reuters
·
Nov 12

Ovid Therapeutics reports Q3 revenue of $132,000 and R&D expenses of $5.9 million

Reuters
·
Nov 12

BRIEF-Ovid Therapeutics Q3 EPS USD -0.17

Reuters
·
Nov 12

Ovid Therapeutics Names Meg Alexander as CEO

Reuters
·
Nov 12

Ovid Therapeutics Q3 Revenue USD 132 Thousand VS. Ibes Estimate USD 153.3 Thousand

THOMSON REUTERS
·
Nov 12

Ovid Therapeutics Inc - Jeremy M. Levin to Transition to Executive Chair of Bod

THOMSON REUTERS
·
Nov 12

Ovid Therapeutics Inc - Meg Alexander Appointed CEO Effective January 1, 2026

THOMSON REUTERS
·
Nov 12

Press Release: Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

Dow Jones
·
Nov 12

Ovid Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
Nov 07

Ovid Therapeutics Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Oct 28

Oppenheimer upgrades Ovid Therapeutics (OVID) to a Buy

TIPRANKS
·
Oct 09

William Blair Sticks to Its Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
Oct 04

BUZZ-U.S. STOCKS ON THE MOVE-Occidental Petroleum , GameStop, Alphabet

Reuters
·
Oct 03

Exchange-Traded Funds, Equity Futures Higher Pre-Bell as Investors Eye Another Interest Rate Cut for 2025

MT Newswires Live
·
Oct 03

Ovid Therapeutics Agrees to Financing Deal Worth up to $175 million

MT Newswires Live
·
Oct 03

BUZZ-Ovid Therapeutics jumps after seizure treatment shows promise in trial

Reuters
·
Oct 03